Form 4: Amgen CEO Robert Bradway Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Amgen's Chairman, CEO, and President, Robert A. Bradway, disposed of 20,560 shares of common stock on March 18, 2024, to satisfy tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).
Summary
- On March 18, 2024, Robert A. Bradway, Chairman, CEO, and President of Amgen Inc., disposed of 20,560 shares of Amgen common stock.
- The transaction was executed at a price of $268.87 per share.
- This disposition was to cover tax obligations related to the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Bradway still beneficially owns 664,077 shares of Amgen common stock, which includes various RSUs vesting at different dates in the future.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine transaction. It doesn't inherently convey positive or negative sentiment.
Future Outlook
The document does not contain any specific forward-looking statements regarding the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The disposal of shares to cover tax obligations is a common practice among executives who receive equity compensation.
Comparison to Industry Standards
- Executive compensation practices, including the use of RSUs, are common across the pharmaceutical and biotechnology industries.
- Companies like Johnson & Johnson, Pfizer, and Merck also utilize equity-based compensation for their executives.
- The vesting schedules and tax implications associated with RSUs are generally similar across these companies.
Stakeholder Impact
- The transaction has a minimal direct impact on shareholders, as it is a routine disposal of shares by an executive for tax purposes.
- The disposal does not indicate any change in the executive's confidence in the company's future prospects, as they still hold a significant number of shares.
Key Dates
| Date | Description |
|---|---|
| 03/18/2024 | Date of stock disposal transaction. |
| 05/05/2024 | Vesting date for 4,143 RSUs. |
| 04/30/2024 | Vesting date for 4,382 RSUs. |
| 04/30/2025 | Vesting date for 4,516 RSUs. |
| 05/02/2024 | Vesting date for 4,547 RSUs. |
| 05/02/2025 | Vesting date for 8,998 RSUs (4,450 + 4,548). |
| 05/02/2026 | Vesting date for 9,236 RSUs (4,686 + 4,550). |
| 05/02/2027 | Vesting date for 4,586 RSUs. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.